HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia

Tissue Antigens

Volumn 75, Issue 2, 2010, Pages 127-135

  De Re, V ^a,b   Caggiari, L ^a   Monti, G ^b   Libra, M ^c   Spina, M ^a   Dolcetti, R ^a   De Zorzi, M ^a   Racanelli, V ^d   Crovatto, M ^e   Toffoli, G ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b Dr Giuseppe Monti for the Italian Group ALCRI   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e S MARIA DEGLI ANGELI HOSPITAL   (Italy)

Author keywords

Autoimmunity; B cells; Hepatitis C virus; Lymphoma; Molecules major histocompatibility complex

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; CRYOGLOBULINEMIA; HEPATITIS C VIRUS; HLA SYSTEM; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ALLELES; CRYOGLOBULINEMIA; HEPACIVIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; LYMPHOMA, NON-HODGKIN; RISK;

HEPATITIS C VIRUS;

EID: 73949089660     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2009.01414.x     Document Type: Article

References (35)

1. Sansonno D, Carbone A, De Re V, Dammacco F. Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) 2007 : 46 : 572 578.
2. De Re V, De Vita S, Marzotto A et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 2000 : 96 : 3578 3584.
3. De Re V, De Vita S, Sansonno D et al. Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses. Rheumatology (Oxford) 2006 : 45 : 685 693.
4. De Re V, De Vita S, Sansonno D, Toffoli G. Mixed cryoglobulinemia syndrome as an additional autoimmune disorder associated with risk for lymphoma development. Blood 2008 : 111 : 5760.
5. De Re V, Caggiari L, Simula MP, De Vita S, Sansonno D, Dolcetti R. B-cell lymphomas associated with HCV infection. Gastroenterology 2007 : 132 : 1205 1207.
6. De Re V, De Vita S, Gasparotto D et al. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas. Eur J Immunol 2002 : 32 : 903 910.
7. De Re V, Sansonno D, Simula MP et al. HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations. Leukemia 2006 : 20 : 1145 1154.
8. + regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 2004 : 103 : 3428 3430.
9. Parker DC. T cell-dependent B cell activation. Annu Rev Immunol 1993 : 11 : 331 350.
10. De Re V, Caggiari L, Talamini R et al. Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles. Hum Immunol 2004 : 65 : 1397 1404.
11. De Re V, Caggiari L, De Vita S et al. Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. Dig Liver Dis 2007 : 39 : S63 9.
12. De Re V, Caggiari L, Simula MP et al. Role of the HLA class II: HCV-related disorders. Ann N Y Acad Sci 2007 : 1107 : 308 318.
13. Cacoub P, Renou C, Kerr G et al. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum 2001 : 44 : 2118 2124.
14. Lenzi M, Frisoni M, Mantovani V et al. Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia. Blood 1998 : 91 : 2062 2066.
15. Nieters A, Kallinowski B, Brennan P et al. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study epilymph. Gastroenterology 2006 : 131 : 1879 1886. (Pubitemid 44958516)
16. Mele A, Pulsoni A, Bianco E et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 2003 : 102 : 996 999.
17. Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2006 : 15 : 2078 2085.
18. Silvestri F, Barillari G, Fanin R et al. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas. Haematologica 1997 : 82 : 314 317. (Pubitemid 28023307)
19. Monti G, Pioltelli P, Saccardo F et al. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med 2005 : 165 : 101 105.
20. Ferri C, Sebastiani M, Giuggioli D et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004 : 33 : 355 374.
21. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974 : 57 : 775 788.
22. Dinauer DM, Luhm RA, Uzgiris AJ. Sequence-based typing of HLA class II DQB1. Tissue Antigens 2000 : 55 : 364 368.
23. Kotsch K, Wehling J, Blasczyk R. Sequencing of HLA class II genes based on the conserved diversity of the non-coding regions: sequencing based typing of HLA-DRB genes. Tissue Antigens 1999 : 53 : 486 497.
24. Doytchinova IA, Flower DR. In silico identification of supertypes for class II MHCs. J Immunol 2005 : 174 : 7085 7095.
25. Harris RA, Sugimoto K, Kaplan DE, Ikeda F, Kamoun M, Chang KM. Human leukocyte antigen class II associations with hepatitis C virus clearance and virus-specific CD4 T cell response among Caucasians and African Americans. Hepatology 2008 : 48 : 70 9.
26. Alric L, Fort M, Izopet J et al. Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance. Tissue Antigens 2000 : 56 : 154 158.
27. Godkin A, Jeanguet N, Thursz M, Openshaw P, Thomas H. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients. Eur J Immunol 2001 : 31 : 1438 1446.
28. Thursz M, Yallop R, Goldin R, Trepo C, Thomas HC. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet 1999 : 354 : 2119 2124.
29. Lamonaca V, Missale G, Urbani S et al. Conserved hepatitis C virus sequences are highly immunogenic for CD 4(+) T cells: implications for vaccine development. Hepatology 1999 : 30 : 1088 1098.
30. Diepolder M, Gerlach JT, Zachoval R et al. Immunodominant CD 4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol 1997 : 71 : 6011 6019.
31. McKiernan SM, Hagan R, Curry M et al. Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 2004 : 40 : 108 114.
32. Barrett S, Ryan E, Crowe J. Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin. J Hepatol 1999 : 30 : 979 983.
33. De Groot AS, Rayner J, Martin W. Modelling the immunogenicity of therapeutic proteins using T cell epitope mapping. Dev Biol (Basel) 2003 : 112 : 71 80.
34. De Re V, Pavan A, Sansonno S, Sansonno D, Racanelli V. Clonal CD 27 + CD19+ B-cell expansion through inhibition of FcγIIR in HCV + cryoglobulinemic patients. Ann N Y Acad Sci 2009 : 1173 : 326 333.
35. Tedeschi A, Baratè C, Minola E, Morra E. Cryoglobulinemia. Blood Rev 2007 : 21 : 183 200.